CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma MicroenvironmentTomohiro Fujiwara, John H. Healey, Mohamed A. Yakoub et al.|Molecular Cancer Therapeutics|2021Cited by 258
Soft-tissue sarcoma in adolescents and young adultsToshiyuki Kunisada, Toshifumi Ozaki, Eiji Nakata et al.|International Journal of Clinical Oncology|2022Cited by 61
Role of Tumor-Associated Macrophages in SarcomasTomohiro Fujiwara, Toshifumi Ozaki, Hiroya Kondo et al.|Cancers|2021Cited by 54
Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcomaYusuke Mochizuki, Toshiyoshi Fujiwara, Toshifumi Ozaki et al.|Cancer Immunology Immunotherapy|2020Cited by 29
Discovery of a Novel Aminocyclopropenone Compound That Inhibits BRD4-Driven Nucleoporin NUP210 Expression and Attenuates Colorectal Cancer GrowthHiroya Kondo, Richard W. Wong|Cells|2022Cited by 19